Applied research in infectious respiratory diseases and critically ill patients
Featured publications
-
Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I
Ramos, Daniel; Francesqui, Joel; Bollo, Elena; Villar, Ana; Florez, Pablo;(...)Gomez-Carrera, Luis; Bonilla, Gema; Millan-Billi, Paloma; Hernandez-Gonzalez, Fernanda; Sellares, Jacobo.Reference:RESPIRATORY MEDICINE 2026.
-
Organizing pneumonia in hospitalized COVID-19 patients: risk factors and long-term outcomes
Cuerpo, Sandra; Hernandez-Gonzalez, Fernanda; Benegas, Mariana; Albacar, Nuria; Lopez-Giraldo, Alejandra;(...)Sibila, Oriol; Sanchez, Marcelo; Agusti, Alvar; Garcia-Aymerich, Judith; Sellares, Jacobo.Reference:Pneumonia (Nathan) 2025.
-
Pirfenidone in post-COVID-19 pulmonary fibrosis (FIBRO-COVID): a phase 2 randomised clinical trial
Bermudo-Peloche, Guadalupe; Del Rio, Belen; Vicens-Zygmunt, Vanesa; Bordas-Martinez, Jaume; Hernandez, Marta;(...)Fuentes, Mireya; Montes-Worboys, Ana; Franquet, Tomas; Luburich, Patricio; Molina-Molina, Maria.Reference:EUROPEAN RESPIRATORY JOURNAL 2025.
-
Lung immune signatures define two groups of end-stage IPF patients
Cruz, T; Mendoza, N; Casas-Recasens, S; Noell, G; Hernandez-Gonzalez, F;(...)Molina, M; Rojas, M; Agusti, A; Sellares, J; Faner, R.Reference:RESPIRATORY RESEARCH 2023.
-
Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression
Mendoza, N; Casas-Recasens, S; Olvera, N; Hernandez-Gonzalez, F; Cruz, T;(...)Robres, L; Rojas, M; Agustí, A; Sellaées, J; Faner, R.Reference:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023.
